IL138137A - Cholenic acid amides and pharmaceutical compositions thereof - Google Patents
Cholenic acid amides and pharmaceutical compositions thereofInfo
- Publication number
- IL138137A IL138137A IL13813799A IL13813799A IL138137A IL 138137 A IL138137 A IL 138137A IL 13813799 A IL13813799 A IL 13813799A IL 13813799 A IL13813799 A IL 13813799A IL 138137 A IL138137 A IL 138137A
- Authority
- IL
- Israel
- Prior art keywords
- pharmaceutical compositions
- acid amides
- cholenic acid
- cholenic
- amides
- Prior art date
Links
- HIAJCGFYHIANNA-QIZZZRFXSA-N 3b-Hydroxy-5-cholenoic acid Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@@H](CCC(O)=O)C)[C@@]1(C)CC2 HIAJCGFYHIANNA-QIZZZRFXSA-N 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
- C07J43/003—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/18—Drugs for disorders of the endocrine system of the parathyroid hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
- C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
- C07J41/0055—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by an uninterrupted chain of at least three carbon atoms which may or may not be branched, e.g. cholane or cholestane derivatives, optionally cyclised, e.g. 17-beta-phenyl or 17-beta-furyl derivatives
- C07J41/0061—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by an uninterrupted chain of at least three carbon atoms which may or may not be branched, e.g. cholane or cholestane derivatives, optionally cyclised, e.g. 17-beta-phenyl or 17-beta-furyl derivatives one of the carbon atoms being part of an amide group
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physical Education & Sports Medicine (AREA)
- Immunology (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Neurology (AREA)
- Diabetes (AREA)
- Biomedical Technology (AREA)
- Pulmonology (AREA)
- Endocrinology (AREA)
- Neurosurgery (AREA)
- Transplantation (AREA)
- Communicable Diseases (AREA)
- Hospice & Palliative Care (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Obesity (AREA)
- Heart & Thoracic Surgery (AREA)
- Dermatology (AREA)
- Cardiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9804861.4A GB9804861D0 (en) | 1998-03-06 | 1998-03-06 | Chemical compounds |
| PCT/GB1999/000681 WO1999045024A1 (en) | 1998-03-06 | 1999-03-08 | Cholenic acid amides and pharmaceutical compositions thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IL138137A0 IL138137A0 (en) | 2001-10-31 |
| IL138137A true IL138137A (en) | 2005-11-20 |
Family
ID=10828156
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL13813799A IL138137A (en) | 1998-03-06 | 1999-03-08 | Cholenic acid amides and pharmaceutical compositions thereof |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US7235552B1 (enExample) |
| EP (1) | EP1060188A1 (enExample) |
| JP (1) | JP2002505336A (enExample) |
| KR (1) | KR100690037B1 (enExample) |
| CN (1) | CN1177860C (enExample) |
| AU (1) | AU752992B2 (enExample) |
| CA (1) | CA2319763C (enExample) |
| CZ (1) | CZ298478B6 (enExample) |
| GB (1) | GB9804861D0 (enExample) |
| HU (1) | HUP0100854A3 (enExample) |
| IL (1) | IL138137A (enExample) |
| NO (1) | NO317378B1 (enExample) |
| NZ (1) | NZ506139A (enExample) |
| WO (1) | WO1999045024A1 (enExample) |
| ZA (1) | ZA991841B (enExample) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ523042A (en) * | 2000-05-11 | 2004-05-28 | Res Inst Medicine Chem | 2-substituted pregna-1, 3, 5 (10) -triene and chola-1, 3, 5 (10)-triene derivatives and their biological activity |
| EP1514874A1 (en) * | 2003-07-28 | 2005-03-16 | Schering Aktiengesellschaft | Thiomorpholino steroid compounds, the use thereof for the preparation of meiosis regulating medicaments and method for the preparation thereof |
| WO2009059239A2 (en) * | 2007-11-02 | 2009-05-07 | Mayo Foundation For Medical Education And Research | REDUCING Aβ42 LEVELS AND Aβ AGGREGATION |
| WO2010065936A1 (en) | 2008-12-04 | 2010-06-10 | Chongxi Yu | High penetration compositions and their applications |
| US8987235B2 (en) | 2011-05-17 | 2015-03-24 | Wisconsin Alumni Research Foundation | N-cyclopropyl-(20R)-2-methylene-19,26,27-trinor-25-aza-vitamin D analogs and their uses |
| CA2842462C (en) | 2011-07-20 | 2020-01-28 | Brigham Young University | Hydrogel materials incorporating eluting ceragenin compound |
| RU2669800C2 (ru) | 2013-03-15 | 2018-10-16 | Брихэм Янг Юниверсити | Способы лечения воспаления, аутоиммунных расстройств и боли |
| US11524015B2 (en) | 2013-03-15 | 2022-12-13 | Brigham Young University | Methods for treating inflammation, autoimmune disorders and pain |
| US11690855B2 (en) | 2013-10-17 | 2023-07-04 | Brigham Young University | Methods for treating lung infections and inflammation |
| US20150203527A1 (en) | 2014-01-23 | 2015-07-23 | Brigham Young University | Cationic steroidal antimicrobials |
| US9434759B1 (en) * | 2015-05-18 | 2016-09-06 | Brigham Young University | Cationic steroidal antimicrobial compounds and methods of manufacturing such compounds |
| US10226550B2 (en) | 2016-03-11 | 2019-03-12 | Brigham Young University | Cationic steroidal antimicrobial compositions for the treatment of dermal tissue |
| EP3275888B1 (en) * | 2016-07-28 | 2019-09-25 | Council of Scientific & Industrial Research | Progesterone-cationic lipid hybrid as anticancer agent and the process of synthesis thereof |
| US10959433B2 (en) | 2017-03-21 | 2021-03-30 | Brigham Young University | Use of cationic steroidal antimicrobials for sporicidal activity |
| US12186328B2 (en) | 2019-05-23 | 2025-01-07 | Brigham Young University | Use of CSA compounds to stimulate stem cells and hair growth |
| WO2023205801A2 (en) | 2022-04-22 | 2023-10-26 | Asteroid Therapeutics | Steroidal compositions and methods of treating lipogenic cancers |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR1512326A (fr) * | 1964-03-27 | 1968-02-09 | Roussel Uclaf | Nouveaux stéroïdes azotés et procédé de préparation |
| US4217288A (en) * | 1977-03-24 | 1980-08-12 | Wisconsin Alumni Research Foundation | Anti-vitamin D compounds |
| US4172076A (en) * | 1977-04-04 | 1979-10-23 | Diamond Shamrock Corporation | Process for preparing steroidal acids and their intermediate derivatives |
| DE2920092A1 (de) * | 1978-05-19 | 1979-11-29 | Wisconsin Alumni Res Found | Antivitamin d-verbindungen und diese enthaltende pharmazeutische zusammensetzungen |
| GB8505862D0 (en) * | 1985-03-07 | 1985-04-11 | Erba Farmitalia | Steroidic 5alpha-reductase inhibitors |
| US5494905A (en) * | 1991-11-07 | 1996-02-27 | Research Institute For Medicine And Chemistry | Vitamin D amide derivatives |
| JP3493037B2 (ja) * | 1991-12-18 | 2004-02-03 | 中外製薬株式会社 | ２２−オキサコレカルシフェロール誘導体とその製造方法 |
| IL105050A0 (en) * | 1992-03-27 | 1993-07-08 | Lilly Co Eli | Steroid derivatives |
| GB9309422D0 (en) * | 1993-05-07 | 1993-06-23 | Res Inst Medicine Chem | Chemical compounds |
| WO1997042215A1 (en) * | 1996-05-06 | 1997-11-13 | Bionumerik Pharmaceuticals, Inc. | Process for preparing 27-hydroxy cholesterol and related derivatives |
| PL334840A1 (en) * | 1997-01-24 | 2000-03-27 | Univ California | Application of fxr, pparalpha and lxralpha activators in order to restore the barrier function, to stimulate epithelium differentation and to inhibit proliferation |
-
1998
- 1998-03-06 GB GBGB9804861.4A patent/GB9804861D0/en not_active Ceased
-
1999
- 1999-03-08 IL IL13813799A patent/IL138137A/xx not_active IP Right Cessation
- 1999-03-08 ZA ZA9901841A patent/ZA991841B/xx unknown
- 1999-03-08 HU HU0100854A patent/HUP0100854A3/hu unknown
- 1999-03-08 NZ NZ506139A patent/NZ506139A/xx unknown
- 1999-03-08 AU AU32675/99A patent/AU752992B2/en not_active Ceased
- 1999-03-08 CA CA002319763A patent/CA2319763C/en not_active Expired - Fee Related
- 1999-03-08 CN CNB998036935A patent/CN1177860C/zh not_active Expired - Fee Related
- 1999-03-08 KR KR1020007009596A patent/KR100690037B1/ko not_active Expired - Fee Related
- 1999-03-08 EP EP99937931A patent/EP1060188A1/en not_active Withdrawn
- 1999-03-08 CZ CZ20003253A patent/CZ298478B6/cs not_active IP Right Cessation
- 1999-03-08 JP JP2000534566A patent/JP2002505336A/ja active Pending
- 1999-03-08 WO PCT/GB1999/000681 patent/WO1999045024A1/en not_active Ceased
-
2000
- 2000-08-01 US US09/630,546 patent/US7235552B1/en not_active Expired - Fee Related
- 2000-09-04 NO NO20004399A patent/NO317378B1/no not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| GB9804861D0 (en) | 1998-04-29 |
| ZA991841B (en) | 1999-09-08 |
| AU3267599A (en) | 1999-09-20 |
| CZ20003253A3 (cs) | 2001-03-14 |
| CA2319763A1 (en) | 1999-09-10 |
| US7235552B1 (en) | 2007-06-26 |
| CA2319763C (en) | 2008-01-15 |
| KR20010041446A (ko) | 2001-05-25 |
| JP2002505336A (ja) | 2002-02-19 |
| IL138137A0 (en) | 2001-10-31 |
| EP1060188A1 (en) | 2000-12-20 |
| KR100690037B1 (ko) | 2007-03-08 |
| AU752992B2 (en) | 2002-10-03 |
| CZ298478B6 (cs) | 2007-10-17 |
| NO20004399D0 (no) | 2000-09-04 |
| NO20004399L (no) | 2000-11-03 |
| CN1292797A (zh) | 2001-04-25 |
| CN1177860C (zh) | 2004-12-01 |
| HUP0100854A3 (en) | 2002-09-30 |
| NO317378B1 (no) | 2004-10-18 |
| WO1999045024A1 (en) | 1999-09-10 |
| NZ506139A (en) | 2003-06-30 |
| HUP0100854A2 (hu) | 2001-09-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUP0100178A3 (en) | Tetrahydro-naphtiridinyl-imidazolydinyl-carboxylic acid derivatives and pharmaceutical compositions thereof | |
| HUP0104495A3 (en) | N-substituted 2-cyanopyrrolidines and pharmaceutical compositions containing them | |
| HUP0103406A3 (en) | 1h-imidazopyridine derivatives and pharmaceutical compositions thereof | |
| HUP0102990A3 (en) | Tetrahydroimidazo-naphtyridine derivatives and pharmaceutical compositions thereof | |
| IL138573A0 (en) | Amide derivatives and pharmaceutical compositions containing the same | |
| IL135177A0 (en) | Amidocarboxylic acid derivatives and pharmaceutical compositions containing the same | |
| HUP9903916A3 (en) | Phosphinic acid amides and pharmaceutical compositions containing the same | |
| HUP0003761A3 (en) | Substituted alkanohydroxamic acids and pharmaceutical compositions containing them | |
| HUP0202254A3 (en) | Amide substituted imidazoquinolines and pharmaceutical compositions containing them | |
| IL146230A0 (en) | 3α-HYDROXY-3β-METHOXYMETHYL-SUBSTITUTED STEROIDS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME | |
| HUP0001309A3 (en) | 1-phenyl-4-benzylpiperazines and pharmaceutical compositions containing them | |
| HUP0103008A3 (en) | Phenoxyacetic acid derivatives and medicinal compositions containing the same | |
| HUP0101381A3 (en) | Benzofurylpyrone derivatives and pharmaceutical compositions containing them | |
| HUP0002510A3 (en) | Tetrazole derivatives and pharmaceutical compositions containing them | |
| IL138137A0 (en) | Cholenic acid amides and pharmaceutical compositions thereof | |
| HUP0103203A3 (en) | Azaadamantane derivatives and pharmaceutical compositions thereof | |
| HUP0104985A3 (en) | Pharmaceutical levothyroxine compositions and process for their preparation | |
| HUP0100085A3 (en) | Biphenylamidine derivatives and pharmaceutical compositions containing them | |
| HUP0002331A3 (en) | 20-aralkyl-5alpha-pregnane derivatives and pharmaceutical compositions thereof | |
| ZA9811655B (en) | Phenylaminoalkylcarboxylic acid derivatives and pharmaceutical compositions comprising the same | |
| HUP0101701A3 (en) | Substituted betha-alanines and pharmaceutical compositions comprising them | |
| HUP0101733A3 (en) | Pharmaceutical compositions containing sulfonyl-dipeptides and their use | |
| HUP0000460A3 (en) | Imidazopyridazines and pharmaceutical compositions thereof | |
| GB9803521D0 (en) | New compounds and pharmaceutical compositions thereof | |
| HUP0201443A3 (en) | 1-trifluoromethyl-4-hydroxy-7-piperidinyl-aminomethylchroman derivatives and pharmaceutical compositions containing them |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FF | Patent granted | ||
| KB | Patent renewed | ||
| MM9K | Patent not in force due to non-payment of renewal fees |